Ranibizumab for Neovascular Age-Related Macular Degeneration
Abstract
Ranibizumab — a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A — has been evaluated for the treatment of neovascular age-related macular...
Paper Details
Title
Ranibizumab for Neovascular Age-Related Macular Degeneration
Published Date
Oct 5, 2006
Volume
355
Issue
14
Pages
1419 - 1431
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History